Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing HTAs by Skåne University Hospital in Sweden in December 2024

In December 2024, the Skåne University Hospital (HTA South) is working on health technology assessments in several areas, including men’s health and neurology. Some examples can be found below:

  • Organized prostate cancer screening (health economic analysis);
  • Alternative treatments for benign prostatic hyperplasia, including green laser vaporization compared to TUR-P;
  • Effect on the quality of life, pain relief, and complication risks of intrathecal pain treatment with implantable pump compared to external pump or conventional pain treatment of malignant pain in people with cancer in the palliative stage.

The full details in Swedish can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.